Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunwha Pharmaceuticals
South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
Kunwha Pharmaceuticals was a generic pharmaceutical manufacturer focused on commercial products including anti-obesity drugs; merged with Dream Pharma and rebranded to Alvogen Korea in 2015.
- Therapeutic areas
- Endocrinology
- Modalities
- Small molecule
- Industry
- Biotech
02
Partnerships
BioDelivery Sciences International (license for ONSOLIS in South Korea)AlvogenLotus PharmaceuticalsDream Pharma
Beyond the preview
Go deeper on Kunwha Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kunwha Pharmaceuticals.